Showing 16,761 - 16,780 results of 44,201 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((c decrease) OR (a decrease)) ))', query time: 1.34s Refine Results
  1. 16761
  2. 16762
  3. 16763

    Transcriptomic response to USF depletion and ionizing radiation. by Kimberly S. Bellingham-Johnstun (21714063)

    Published 2025
    “…Data represents the log2 ratio of RMA-normalized intensity data for each sample relative to the mean of the genotype-matched no IR samples. Red color represents increased expression, blue represents decreased expression and grey denotes no change. …”
  4. 16764
  5. 16765
  6. 16766
  7. 16767

    Iron parameters and reference values. by Eliana da Costa Alvarenga de Brito (16426022)

    Published 2023
    “…The forms of iron before treatment and at the time of clinical cure were evaluated based on the following: serum ferritin levels (storage iron); total iron-binding capacity (TIBC) and transferrin saturation (TSAT) level (transport iron); red blood cell (RBC), hemoglobin (Hb), hematocrit (HCT), and soluble transferrin receptor (sTfR) levels; and sTfR/log ferritin ratio (functional iron). The mean age of the patients was 54.5 years (±6.7 years). …”
  8. 16768

    Dataset containing variables of the study. by Eliana da Costa Alvarenga de Brito (16426022)

    Published 2023
    “…The forms of iron before treatment and at the time of clinical cure were evaluated based on the following: serum ferritin levels (storage iron); total iron-binding capacity (TIBC) and transferrin saturation (TSAT) level (transport iron); red blood cell (RBC), hemoglobin (Hb), hematocrit (HCT), and soluble transferrin receptor (sTfR) levels; and sTfR/log ferritin ratio (functional iron). The mean age of the patients was 54.5 years (±6.7 years). …”
  9. 16769
  10. 16770
  11. 16771
  12. 16772
  13. 16773

    Patient demographics. by Shuu Morita (17904251)

    Published 2024
    “…The mean medication burden decreased significantly from 2.5 to 1.1 for iStent (55.0% reduction, <i>P</i><0.01) and 2.9 to 1.7 for iStent inject (46.8% reduction, <i>P</i><0.01), with no significant differences between the two groups (<i>P</i> = 0.17). …”
  14. 16774

    S1 Dataset - by Shuu Morita (17904251)

    Published 2024
    “…The mean medication burden decreased significantly from 2.5 to 1.1 for iStent (55.0% reduction, <i>P</i><0.01) and 2.9 to 1.7 for iStent inject (46.8% reduction, <i>P</i><0.01), with no significant differences between the two groups (<i>P</i> = 0.17). …”
  15. 16775

    Complications. by Shuu Morita (17904251)

    Published 2024
    “…The mean medication burden decreased significantly from 2.5 to 1.1 for iStent (55.0% reduction, <i>P</i><0.01) and 2.9 to 1.7 for iStent inject (46.8% reduction, <i>P</i><0.01), with no significant differences between the two groups (<i>P</i> = 0.17). …”
  16. 16776

    Cyclin G2 is a target of calpain-mediated proteolysis. by Stefanie Bernaudo (4167634)

    Published 2017
    “…OV2008 cells were transiently transfected with the FLAG-CCNG2 plasmid and treated with or without 50μM calpeptin for 2h or 6h. Western blot analysis demonstrated a protective effect of calpeptin on cyclin G2 stability. …”
  17. 16777
  18. 16778

    Reconsideration of the Effects of Age on Proximal Femur Structure: Implications for Joint Replacement and Hip Fracture by B. C. C. Khoo (3239391)

    Published 2016
    “…</p><p>Results</p><p>Over the adult life span total integral volumes at the FN, TR and IT sites expand linearly by between 18 and 37% at the same time as bone mass decreased by 22 to 25% resulting in massive reductions in true volumetric BMD (vBMD) of 40 to 50%. …”
  19. 16779

    Image1_CGX, a standardized herbal syrup, inhibits colon-liver metastasis by regulating the hepatic microenvironments in a splenic injection mouse model.DOCX by Sung-Bae Lee (6835907)

    Published 2022
    “…<p>Background: Colon-liver metastasis is observed in approximately 50% of patients with colorectal cancer and is a critical risk factor for a low survival rate. …”
  20. 16780

    Image1_CGX, a standardized herbal syrup, inhibits colon-liver metastasis by regulating the hepatic microenvironments in a splenic injection mouse model.tif by Sung-Bae Lee (6835907)

    Published 2022
    “…<p>Background: Colon-liver metastasis is observed in approximately 50% of patients with colorectal cancer and is a critical risk factor for a low survival rate. …”